Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK598880PMID: 38163334
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 35121-78-9
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of epoprostenol during breastfeeding. The half-life of epoprostenol is 6 minutes or less. It is unlikely that clinically important amounts of epoprostenol are excreted into milk and absorbed by the breastfed infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Epoprostenol
CAS Registry Number
35121-78-9
Drug Class
Breast Feeding
Milk, Human
Cardiovascular Agents
Prostaglandins, Synthetic
Vasodilator Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Dinoprostone.[Drugs and Lactation Database (...]Review Dinoprostone.. Drugs and Lactation Database (LactMed®). 2006
- Stimulation of prostacyclin synthesis by thromboxane A2-like prostaglandin endoperoxide analogues in cultured vascular smooth muscle cells.[Biochem Biophys Res Commun. 1984]Stimulation of prostacyclin synthesis by thromboxane A2-like prostaglandin endoperoxide analogues in cultured vascular smooth muscle cells.Hassid A. Biochem Biophys Res Commun. 1984 Aug 30; 123(1):21-6.
- Functional pharmacology of human prostanoid EP2 and EP4 receptors.[Eur J Pharmacol. 2004]Functional pharmacology of human prostanoid EP2 and EP4 receptors.Wilson RJ, Rhodes SA, Wood RL, Shield VJ, Noel LS, Gray DW, Giles H. Eur J Pharmacol. 2004 Oct 6; 501(1-3):49-58.
- Human platelet aggregation induced by prostaglandin endodisulfide.[Prostaglandins. 1977]Human platelet aggregation induced by prostaglandin endodisulfide.Okuma M, Yoshimoto T, Yamamoto S. Prostaglandins. 1977 Nov; 14(5):891-6.
- Review Misoprostol.[Drugs and Lactation Database (...]Review Misoprostol.. Drugs and Lactation Database (LactMed®). 2006
- Epoprostenol - Drugs and Lactation Database (LactMed®)Epoprostenol - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...